Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximo Rivero-Ayerza

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Cardiac Failure|September 4, 2019
Predicting Early Mortality Among Implantable Defibrillator Patients Treated With Cardiac Resynchronization TherapyDominic A M J Theuns, Nick Van Boven, Beat A Schaer, et al.
Journal of Cardiac Failure|November 13, 2012
Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodelingFrederik H Verbrugge, Matthias Dupont, Maximo Rivero-Ayerza, et al.
NPJ Digital Medicine|November 20, 2025
Fibricheck detection capabilities for atrial fibrillation (FDA-AF): a multicenter validation studyJohn Sollee, Baljash Cheema, David Slotwiner, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 17, 2024
Real-world validation of smartphone-based photoplethysmography for rate and rhythm monitoring in atrial fibrillationHenri Gruwez, Daniel Ezzat, Tim Van Puyvelde, et al.
The American Journal of Cardiology|January 15, 2016
Long-Term Performance of the Riata/ST Implantable Cardioverter-Defibrillator LeadErwin Ströker, Carlo de Asmundis, Philippe Vanduynhoven, et al.
Circulation. Arrhythmia and Electrophysiology|November 3, 2023
No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 TrialAnthony Demolder, Louisa O'Neill, Milad El Haddad, et al.
European Heart Journal|September 3, 2014
EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoringHein Heidbuchel, Gerd Hindricks, Paul Broadhurst, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Cardiac Failure|September 4, 2019
Predicting Early Mortality Among Implantable Defibrillator Patients Treated With Cardiac Resynchronization TherapyDominic A M J Theuns, Nick Van Boven, Beat A Schaer, et al.
Journal of Cardiac Failure|November 13, 2012
Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodelingFrederik H Verbrugge, Matthias Dupont, Maximo Rivero-Ayerza, et al.
NPJ Digital Medicine|November 20, 2025
Fibricheck detection capabilities for atrial fibrillation (FDA-AF): a multicenter validation studyJohn Sollee, Baljash Cheema, David Slotwiner, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 17, 2024
Real-world validation of smartphone-based photoplethysmography for rate and rhythm monitoring in atrial fibrillationHenri Gruwez, Daniel Ezzat, Tim Van Puyvelde, et al.
The American Journal of Cardiology|January 15, 2016
Long-Term Performance of the Riata/ST Implantable Cardioverter-Defibrillator LeadErwin Ströker, Carlo de Asmundis, Philippe Vanduynhoven, et al.
Circulation. Arrhythmia and Electrophysiology|November 3, 2023
No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 TrialAnthony Demolder, Louisa O'Neill, Milad El Haddad, et al.
European Heart Journal|September 3, 2014
EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoringHein Heidbuchel, Gerd Hindricks, Paul Broadhurst, et al.
Pageof 4